Advanced search
Publication Cover
Diabetes, Metabolic Syndrome and Obesity Volume 15, 2022 - Issue
Submit an article Journal homepage
186
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Infection Rates and Impact of Glucose Lowering Medications on the Clinical Course of COVID-19 in People with Type 2 Diabetes: A Retrospective Observational Study

Francesca Mannucci1 Pharmaceutical Unit, Local Health Unit 6, Padua, Italy
,
Giacomo Vitturi2 Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padua, Italy
,
Luca Benacchio3 Epidemiologic Unit, Local Health Unit 6, Padua, Italy
,
Luca Gino Sbrogiò4 Prevention Department Local Health Unit 6, Padua, Italy
,
Francesca Bano1 Pharmaceutical Unit, Local Health Unit 6, Padua, Italy
,
Annunziata Lapolla5 Diabetology Service, Local Health Unit 6, Padua, Italy
,
Francesco Piarulli5 Diabetology Service, Local Health Unit 6, Padua, Italy
,
Maria Cecilia Giron2 Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padua, Italy
,
Angelo Avogaro6 Department of Medicine, University of Padova, Padua, ItalyORCID Iconhttps://orcid.org/0000-0002-1177-0516
ORCID Icon &
Gian Paolo Fadini6 Department of Medicine, University of Padova, Padua, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6510-2097
ORCID Icon show all
Pages 3093-3101 | Received 10 Aug 2022, Accepted 05 Oct 2022, Published online: 10 Oct 2022

References

  • Hui DS, I Azhar E, Madani TA. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020;91:264–266. doi:10.1016/j.ijid.2020.01.009
  • Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019;17(3):181–192. doi:10.1038/s41579-018-0118-9
  • Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324(8):782–793. doi:10.1001/jama.2020.12839
  • Harrison AG, Lin T, Wang P. Mechanisms of SARS-CoV-2 transmission and pathogenesis. Trends Immunol. 2020;41(12):1100–1115. doi:10.1016/j.it.2020.10.004
  • Pollard CA, Morran MP, Nestor-Kalinoski AL. The COVID-19 pandemic: a global health crisis. Physiol Genomics. 2020;52(11):549–557. doi:10.1152/physiolgenomics.00089.2020
  • Goldstein JR, Lee RD. Demographic perspectives on the mortality of COVID-19 and other epidemics. Proc Natl Acad Sci U S A. 2020;117(36):22035–22041. doi:10.1073/pnas.2006392117
  • Fadini GP, Morieri ML, Longato E, Avogaro A. Prevalence and impact of diabetes among people infected with SARS-CoV-2. J Endocrinol Invest. 2020;43(6):867–869. doi:10.1007/s40618-020-01236-2
  • Varikasuvu SR, Dutt N, Thangappazham B, Varshney S. Diabetes and COVID-19: a pooled analysis related to disease severity and mortality. Prim Care Diabetes. 2021;15(1):24–27. doi:10.1016/j.pcd.2020.08.015
  • Sun B, Huang S, Zhou J. Perspectives of antidiabetic drugs in diabetes with coronavirus infections. Front Pharmacol. 2021;11. doi:10.3389/fphar.2020.592439
  • Jafar N, Edriss H, Nugent K. The effect of short-term hyperglycemia on the innate immune system. Am J Med Sci. 2016;351(2):201–211. doi:10.1016/j.amjms.2015.11.011
  • Lukito AA, Pranata R, Henrina J, Lim MA, Lawrensia S, Suastika K. The effect of metformin consumption on mortality in hospitalized COVID-19 patients: a systematic review and meta-analysis. Diabetes Metab Syndr. 2020;14(6):2177–2183. doi:10.1016/j.dsx.2020.11.006
  • Solerte SB, D’Addio F, Trevisan R, et al. Sitagliptin treatment at the time of hospitalization was associated with reduced mortality in patients with type 2 diabetes and COVID-19: a multicenter, case-control, retrospective, observational study. Dia Care. 2020;43(12):2999–3006. doi:10.2337/dc20-1521
  • Fadini GP, Morieri ML, Longato E, et al. Exposure to dipeptidyl‐peptidase‐4 inhibitors and COVID ‐19 among people with type 2 diabetes: a case‐control study. Diabetes Obes Metab. 2020;22(10):1946–1950. doi:10.1111/dom.14097
  • Schlesinger S, Neuenschwander M, Lang A, et al. Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis. Diabetologia. 2021;64(7):1480–1491. doi:10.1007/s00125-021-05458-8
  • Bonora E, Fedeli U, Schievano E, et al. SARS-CoV-2 and COVID-19 in diabetes mellitus. Population-based study on ascertained infections, hospital admissions and mortality in an Italian region with ∼5 million inhabitants and∼250,000 diabetic people. Nutr Metab Cardiovasc Dis. 2021;31(9):2612–2618. doi:10.1016/j.numecd.2021.06.010
  • Webster P. COVID-19 timeline of events. Nat Med. 2021;27(12):2054–2055. doi:10.1038/s41591-021-01618-w
  • Kumar A, Arora A, Sharma P, et al. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis. Diabetes Metab Syndr. 2020;14(4):535–545. doi:10.1016/j.dsx.2020.04.044
  • Yu B, Li C, Sun Y, Wang DW. Insulin treatment is associated with increased mortality in patients with COVID-19 and type 2 diabetes. Cell Metab. 2021;33(1):65–77.e2. doi:10.1016/j.cmet.2020.11.014
  • Boye KS, Tokar Erdemir E, Zimmerman N, et al. Risk factors associated with COVID-19 hospitalization and mortality: a large claims-based analysis among people with type 2 diabetes mellitus in the United States. Diabetes Ther. 2021;12(8):2223–2239. doi:10.1007/s13300-021-01110-1
  • Khunti K, Knighton P, Zaccardi F, et al. Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England. Lancet Diabetes Endocrinol. 2021;9(5):293–303. doi:10.1016/S2213-8587(21)00050-4
  • Bramante CT, Huling JD, Tignanelli CJ, et al. Randomized trial of metformin, ivermectin, and fluvoxamine for Covid-19. N Engl J Med. 2022;387(7):599–610. doi:10.1056/NEJMoa2201662
  • Montopoli M, Zumerle S, Vettor R, et al. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532). Ann Oncol. 2020;31:1040–1045. doi:10.1016/j.annonc.2020.04.479

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.